CAR-T cells are less sensitive than other types of immunotherapy in detecting and killing melanoma cells, a finding that could help improve immunotherapy sensitivity.
CAR-T cells are less sensitive than other types of immunotherapy in detecting and killing melanoma cells, a finding that could help improve immunotherapy sensitivity.